- Home
- GENI vs LIVN Comparison
GENI vs LIVN Comparison
Compare GENI & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENI
- LIVN
- Stock Information
- Founded
- GENI 2016
- LIVN 1987
- Country
- GENI United Kingdom
- LIVN United Kingdom
- Employees
- GENI N/A
- LIVN N/A
- Industry
- GENI Services-Misc. Amusement & Recreation
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GENI Consumer Discretionary
- LIVN Health Care
- Exchange
- GENI Nasdaq
- LIVN Nasdaq
- Market Cap
- GENI 2.4B
- LIVN 2.1B
- IPO Year
- GENI N/A
- LIVN 1993
- Fundamental
- Price
- GENI $10.37
- LIVN $44.06
- Analyst Decision
- GENI Strong Buy
- LIVN Buy
- Analyst Count
- GENI 13
- LIVN 7
- Target Price
- GENI $11.81
- LIVN $58.57
- AVG Volume (30 Days)
- GENI 4.1M
- LIVN 882.2K
- Earning Date
- GENI 05-06-2025
- LIVN 05-07-2025
- Dividend Yield
- GENI N/A
- LIVN N/A
- EPS Growth
- GENI N/A
- LIVN N/A
- EPS
- GENI N/A
- LIVN N/A
- Revenue
- GENI $535,167,000.00
- LIVN $1,275,380,000.00
- Revenue This Year
- GENI $23.36
- LIVN $5.79
- Revenue Next Year
- GENI $16.28
- LIVN $5.51
- P/E Ratio
- GENI N/A
- LIVN N/A
- Revenue Growth
- GENI 22.89
- LIVN 7.62
- 52 Week Low
- GENI $4.91
- LIVN $32.48
- 52 Week High
- GENI $11.16
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- GENI 51.07
- LIVN 70.16
- Support Level
- GENI $9.91
- LIVN $35.00
- Resistance Level
- GENI $11.40
- LIVN $37.95
- Average True Range (ATR)
- GENI 0.49
- LIVN 1.30
- MACD
- GENI -0.07
- LIVN 1.06
- Stochastic Oscillator
- GENI 50.48
- LIVN 91.36
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.